Safety and Efficacy of Pramipexole in Early Parkinson Disease
- 9 July 1997
- journal article
- clinical trial
- Published by American Medical Association (AMA) in JAMA
- Vol. 278 (2) , 125-130
- https://doi.org/10.1001/jama.1997.03550020057038
Abstract
Research from JAMA — Safety and Efficacy of Pramipexole in Early Parkinson Disease — A Randomized Dose-Ranging StudyKeywords
This publication has 5 references indexed in Scilit:
- Key Papers in Geriatric Psychiatry: mini-mental state: a practical method for grading the cognitive state of patients for the clinician. M. Folstein, S. Folstein and P. McHugh,Journal of Psychiatric Research, 1975,12, 189-198.International Journal of Geriatric Psychiatry, 1998
- Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonistsEuropean Journal of Pharmacology, 1996
- Functional Roles for Dopamine-Receptor SubtypesClinical Neuropharmacology, 1995
- Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonistEuropean Journal of Pharmacology, 1992
- ParkinsonismNeurology, 1967